Department of Dermatology, Kurume University School of Medicine, and Kurume University Institute of Cutaneous Cell Biology, Kurume, Japan.
J Dermatol. 2013 Dec;40(12):962-7. doi: 10.1111/1346-8138.12310. Epub 2013 Oct 22.
We treated 12, 15 and 13 Japanese actinic keratosis (AK) lesions with 5-aminolevulinic acid photodynamic therapy (PDT), 5% imiquimod cream and combination of both therapies, respectively, and compared the effects. Patients underwent the second course, when AK lesions remained after the first course. Efficacy was evaluated 1 month after each treatment. Combination therapy cleared all AK lesions only after the first course, while PDT and imiquimod therapy cleared 41.7% and 66.7% of AK lesions after the first course, respectively. All residual AK lesions after the first course were cleared by the second courses of PDT or imiquimod therapy. During the course, erosion and crust developed significantly more frequently in combination therapy (P < 0.001). Most Japanese AK lesions can be satisfactorily treated with either PDT or imiquimod monotherapy. However, only severe cases may better be treated with combination therapy, which show higher efficacy even though adverse events occur frequently.
我们分别用 5-氨基酮戊酸光动力疗法(PDT)、5%咪喹莫特乳膏和两者联合疗法治疗了 12、15 和 13 例日本光化性角化病(AK)病变,并比较了疗效。当第一次疗程后 AK 病变仍存在时,患者接受了第二次疗程。每次治疗后 1 个月评估疗效。联合治疗仅在第一次疗程后即可清除所有 AK 病变,而 PDT 和咪喹莫特治疗则分别在第一次疗程后清除了 41.7%和 66.7%的 AK 病变。第一次疗程后的所有残余 AK 病变均通过 PDT 或咪喹莫特的第二次疗程清除。在治疗过程中,联合治疗中明显更频繁地出现糜烂和结痂(P < 0.001)。大多数日本 AK 病变可以通过 PDT 或咪喹莫特单一疗法得到满意的治疗。然而,只有严重的病例可能通过联合治疗更好地治疗,尽管经常发生不良反应,但该治疗具有更高的疗效。